NEWS & RESOURCES

Bioscience

Positive Session for Bioscience Sector

The 2026 General Assembly session was one of the least contentious in recent memory for the biopharma sector. Bills calling for innovation-sapping price controls and unworkable programs…

News

Boehringer Partners on Connecticut Science Center STEM Lab

The Connecticut Science Center is home to exhibits, programs, and…

News

Costly Public Option Precursor Advances

The Connecticut General Assembly is exploring ways to address rising…

Content Type:

Bioscience

03.03.2017

Rare Disease Day Highlights Work of State Biopharmas

Rare Disease Day was recognized worldwide Feb. 28, including...

Bioscience

02.24.2017

The Fog of Healthcare Policy

Seasoned, battle-scarred military strategists often speak of the debilitating...

Bioscience

01.20.2017

The Virtues of Biosimilars

This year, Connecticut has the opportunity to adopt legislation...

Bioscience

01.03.2017

Solving State’s Problems Requires Political Will

The 2017 General Assembly session opens Jan. 4 with Connecticut,...

Bioscience

10.25.2016

State Improves in National High-Tech Rankings

Connecticut climbed three places to sixth overall in the Milken...

Bioscience

06.02.2016

DECD’s Business Ambassador Program

CBIA talks with Connecticut Department of Economic and Community...

Bioscience

05.31.2016

The Truth Behind Prescription Drug Pricing

Prescription medicines account for only about 10% of healthcare...

Bioscience

04.15.2016

Opioid Tax Sets Bad Precedent

A proposal to tax prescription opioid medicines has its...

Bioscience

03.24.2016

An Innovative Connecticut?

Connecticut is, and always has been, one of the...

Stay Connected with CBIA News Digests

The latest news and information delivered directly to your inbox.

Economy

HR & Safety

Issues & Policies

Manufacturing

Member News

Media Center

Small Business

Workforce

Take Action

Bioscience

Positive Session for Bioscience Sector

Boehringer Partners on Connecticut Science Center STEM Lab

Costly Public Option Precursor Advances

Rare Disease Day Highlights Work of State Biopharmas

The Fog of Healthcare Policy

The Virtues of Biosimilars

Solving State’s Problems Requires Political Will

State Improves in National High-Tech Rankings

DECD’s Business Ambassador Program

The Truth Behind Prescription Drug Pricing

Opioid Tax Sets Bad Precedent

An Innovative Connecticut?

Stay Connected with CBIA News Digests

2025 Manufacturing Tour

Company Name & Address

Company Contact Info